Government Pricing October 11, 2021 Frequently Asked Questions: 340B Program 3 Minute Read Examining common questions about the 340B program and what ICyte solutions are available to identify and act on non-compliance.
Government Pricing October 4, 2021 Updates to State Price Transparency Laws 2 Minute Read As more states begin to adopt price transparency laws, we examine the latest laws enacted by individual states and what it means for manufacturers.
Channel September 24, 2021 Refined Channel Data: Inventory Analytics 3 Minute Read How IntegriChain’s Inventory Analytics helps manufacturers conquer the complexity of inventory estimation.
Contracts & Pricing September 17, 2021 How Discount Cards Are Replacing PBMs 3 Minute Read We review how discount cards have disrupted the prescription market as well as updates to the most-favored-nation pricing model and new STPR laws in Maine.
Channel August 23, 2021 Refined Channel Data: Unblinding 3 Minute Read Unblinding national datasets gives Life Sciences manufacturers a clear view into where and when their therapies are being utilized.
Contracts & Pricing August 13, 2021 Compliance Guidelines for Government Programs 5 Minute Read Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.
Contracts & Pricing July 26, 2021 The Branded Pharma Fee Deadline Approaches 4 Minute Read We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.
ICyte Platform July 8, 2021 Breaking down the Silos for Next-Generation Access 5 Minute Read This blog is the fourth in a series that shares our vision for future-proofing Market Access. Manufacturers can evolve the Market Access function to work toward their commercial, financial, and...
Patient Access July 1, 2021 Frequently Asked Questions – Data Aggregation 3.0 3 Minute Read As channels evolve with a shift toward precision medicines, larger patient access obstacles have emerged, and new approaches are needed to transform the world of data aggregation.
